23.22
0.01 (0.04%)
Penutupan Terdahulu | 23.21 |
Buka | 23.30 |
Jumlah Dagangan | 202,316 |
Purata Dagangan (3B) | 817,124 |
Modal Pasaran | 1,075,195,136 |
Harga / Pendapatan (P/E Ke hadapan) | 8.06 |
Harga / Jualan (P/S) | 1.53 |
Harga / Buku (P/B) | 1.35 |
Julat 52 Minggu | |
Tarikh Pendapatan | 28 Jul 2025 - 1 Aug 2025 |
Margin Keuntungan | -14.76% |
Margin Operasi (TTM) | 4.63% |
EPS Cair (TTM) | -2.24 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 1.10% |
Pertumbuhan Pendapatan Suku Tahunan (YOY) | -46.40% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 79.70% |
Nisbah Semasa (MRQ) | 2.41 |
Aliran Tunai Operasi (OCF TTM) | 175.75 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 144.75 M |
Pulangan Atas Aset (ROA TTM) | 3.56% |
Pulangan Atas Ekuiti (ROE TTM) | -12.27% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Bercampur |
Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
Stok | Pacira BioSciences, Inc. | Menaik | Menaik |
AISkor Stockmoo
Konsensus Penganalisis | 1.5 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | -2.0 |
Purata Bergerak Teknikal | 3.5 |
Osilator Teknikal | -0.5 |
Purata | 0.63 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. |
|
Sektor | Healthcare |
Industri | Drug Manufacturers - Specialty & Generic |
Gaya Pelaburan | Small Value |
% Dimiliki oleh Orang Dalam | 1.79% |
% Dimiliki oleh Institusi | 111.09% |
Pemilikan
Nama | Tarikh | Syer Dipegang |
---|---|---|
Doma Perpetual Capital Management Llc | 31 Mar 2025 | 1,804,069 |
Julat 52 Minggu | ||
Median | 30.00 (29.20%) | |
Jumlah | 1 Beli |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
Needham | 09 May 2025 | 30.00 (29.20%) | Beli | 25.12 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |